Biogen Inc. buy BiotechBee
Start price
07.09.22
/
50%
€199.36
Target price
31.12.24
€300.00
Performance (%)
36.69%
End price
30.09.22
€272.50
Summary
This prediction ended on 30.09.22 with a price of €272.50. With a performance of 36.69% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biogen Inc. | -2.983% | -2.983% | -30.846% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to BiotechBee what are the pros and cons of Biogen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Biogen Inc. diskutieren
Buy mit Kursziel 300,0
In the thread Trading Biogen Inc.
Buy beendet
Stopped prediction by BiotechBee for Biogen Inc.
Biogen Inc.
Start price
Target price
Perf. (%)
€272.50
30.09.22
30.09.22
€400.00
31.12.24
31.12.24
4.59%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year